Viewing Study NCT04553692


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-26 @ 9:00 AM
Study NCT ID: NCT04553692
Status: TERMINATED
Last Update Posted: 2025-03-28
First Post: 2020-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Sponsor: IGM Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module